34148025|t|Heterogeneity of Alzheimer's disease
34148025|a|Osszefoglalo. A neurodegenerativ betegsegek kozott az Alzheimer-kor a leggyakoribb korforma. Morbiditasa es mortalitasa vilagszerte egyre gyorsabb utemben novekszik, ezaltal szocialis es gazdasagi hatasa is folyamatosan fokozodo terhet jelent a tarsadalomra. Az elmult nehany evtizedben jelentos elorelepes tortent az Alzheimer-kor megismereseben, szamos biomarker tamogatja a diagnozis felallitasat, tuneti terapiat szolgalo gyogyszerek kerultek bevezetesre. Az Alzheimer-kor klinikai megjelenese, lefolyasa, viselkedese rendkivul valtozatos kepet mutat, felismerese a rendelkezesre allo eszkozok ellenere is kihivast jelenthet a nagy tapasztalattal biro klinikusok szamara is. Munkank celjaul tuztuk ki, hogy osszefoglaljuk az Alzheimer-kor genetikai, patologiai es klinikai jellemzoit, segitve ezzel a betegseg jobb meg- es felismereset. Bemutatjuk a jelenleg ervenyben levo patologiai es klinikai iranyelvek kriteriumrendszereit, az ujabb klasszifikacios szemleleteket. Reszletesen ismertetjuk az Alzheimer-kor heterogenitasat genotipus es fenotipus szintjen egyarant. Elemezzuk a tipusos es atipusos megjelenesi formak jellemzoit, a tarsulo korallapotoknak a megjelenesre es a progressziora gyakorolt hatasat. Orv Hetil. 2021; 162(25): 970-977. Summary. Alzheimer's disease is the most prevalent neurodegenerative disorder. Morbidity and mortality of Alzheimer's disease are increasing worldwide causing important social and economic burden on the society. Over the past few decades, significant progress has been made in the understanding of the pathogenesis of Alzheimer's disease, several biomarkers support the diagnosis and drugs for symptomatic therapy had been introduced. The clinical manifestations and the course of Alzheimer's disease have a variable picture, so - despite the diagnostic opportunities - its diagnosis could be a challenge for highly experienced clinicians as well. The aim of our work was to summarize the genetic, pathological and clinical characteristics of Alzheimer's disease, thus helping to better understand and recognize the disease. We present the criteria systems of the currently valid pathological and clinical guidelines with the most recent classification approaches. The heterogeneity of Alzheimer's disease at both genotype and phenotype levels is described in detail. The characteristics of typical and atypical manifestations and the effect of co-pathologies on the appearance and progression of Alzheimer's disease are also discussed. Orv Hetil. 2021; 162(25): 970-977.
34148025	17	36	Alzheimer's disease	Disease	MESH:D000544
34148025	91	104	Alzheimer-kor	Disease	MESH:D000544
34148025	130	156	Morbiditasa es mortalitasa	Species	
34148025	175	183	gyorsabb	Species	
34148025	211	220	szocialis	Species	
34148025	355	368	Alzheimer-kor	Disease	MESH:D000544
34148025	500	513	Alzheimer-kor	Disease	MESH:D000544
34148025	766	779	Alzheimer-kor	Disease	MESH:D000544
34148025	1038	1067	Alzheimer-kor heterogenitasat	Disease	MESH:D000544
34148025	1296	1315	Alzheimer's disease	Disease	MESH:D000544
34148025	1338	1364	neurodegenerative disorder	Disease	MESH:D019636
34148025	1393	1412	Alzheimer's disease	Disease	MESH:D000544
34148025	1605	1624	Alzheimer's disease	Disease	MESH:D000544
34148025	1768	1787	Alzheimer's disease	Disease	MESH:D000544
34148025	2030	2049	Alzheimer's disease	Disease	MESH:D000544
34148025	2273	2292	Alzheimer's disease	Disease	MESH:D000544
34148025	2484	2503	Alzheimer's disease	Disease	MESH:D000544

